View Document Preview and Link Document Date: 2015-01-12 11:24:30 Open Document File Size: 603,84 KB Share Result on Facebook
Company Prostate Cancer Clinical Trials Working Party Group / / Event FDA Phase / / Facility Removed bridge / / IndustryTerm treatment of metastatic colorectal cancer / treatment of rituximab refractory low grade lymphoma / treatment of metastatic castration resistant prostate cancer / cancer therapy / treatment of recurrent or metastatic cervical cancer / treatment of relapsed/refractory mantle cell lymphoma / treatment of advanced colorectal cancer / treatment of low grade lymphoma / treatment of advanced breast cancer / treatment of relapsed low grade lymphoma / / MedicalCondition Histologically confirmed carcinoma / locally advanced disease / bortezomib naive relapsed multiple myeloma / advanced disease / non-Hodgkin's lymphoma / ovarian cancer / relapsed low grade lymphoma / refractory chronic phase Chronic Myeloid Leukaemia / advanced adenocarcinoma / low grade gliomas / advanced colorectal cancer / lymphoma / Multiple myeloma / residual disease / disease / Colorectal Cancer / IV disease / mantle cell lymphoma / glioma / Triple negative disease / relapsed/refractory mantle cell lymphoma / Documented metastatic disease / visceral disease / metastatic colorectal cancer / primary peritoneal cancer / early disease / persistent disease / bone metastases / leukaemia / low grade lymphoma / relapsed multiple myeloma / Chronic phase Chronic Myeloid Leukaemia / Chronic Lymphocytic Leukaemia / metastatic cervical cancer / renal cell carcinoma / Relapsed disease / sclerotic metastases / resistant prostate cancer / prostate cancer / advanced renal cell carcinoma / advanced breast cancer / rituximab refractory low grade lymphoma / cytologically confirmed adenocarcinoma / stage I-III disease / refractory accelerated phase Chronic Myeloid Leukaemia / / MedicalTreatment adjuvant chemotherapy / combination chemotherapy / anti-cancer therapy / chemotherapy / radiotherapy / surgery / chemotherapies / radiation / / Movie The second line / / Organization NHS / / Person David Thomson / Clarification / Trastuzumab Emtansine / / Position Author / consultant paediatric specialist / appropriate specialist / Drug Indication Changes General General / consultant specialist / / Product Carboplatin / Cisplatin / Paclitaxel / BOS4 / Ver3 / / Technology radiation / Chemotherapy / treating cancer / transplantation / / SocialTag 
National Cancer Drugs Fund List